28 July 2026

Avingtrans Plc

("Avingtrans", the "Company", or the "Group")

PDMR Dealings

Avingtrans plc (AIM: AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, announces that on 28 July 2026, the Company was notified of the exercise of 439,600 options over ordinary shares of 5p each in the Company ("Ordinary Shares") by Steve McQuillan, Chief Executive Officer, Stephen King, Chief Financial Officer and Austen Adams, Chief Operating Officer.

On the same date, the same three PDMRs sold, in aggregate, 397,500 Ordinary Shares at 710 pence per Ordinary Share. The following table summarises the dealings and resultant shareholdings of the three PDMRs:

Issue of Equity

Application has been made for the admission to trading on AIM for the 439,600 new Ordinary Shares ("Admission"). It is expected that Admission will become effective on 3 August 2026.

Total Voting Rights

Following the issue of the 439,600 new Ordinary Shares, the Company will have a total of 37,370,672 Ordinary Shares in issue. The Company does not hold any shares in Treasury. 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

The above information is provided by the Company in accordance with its obligations under the FCA's Disclosure Guidance and Transparency Rules.

  Enquiries: